Breadcrumb
- News and Events
- News
- Content
- The Canadian Institutes for Health Research and Canadian Thoracic Society honour Maziar Divangahi
null The Canadian Institutes for Health Research and Canadian Thoracic Society honour Maziar Divangahi
The RI-MUHC researcher will receive the 2024 CIHR-ICRH/CTS Mid-Career Lecturer Award in Respiratory Sciences
SOURCE: CIHR and RI-MUHC
January 5, 2024
Maziar Divangahi, PhD, was named the 2024 Mid-Career Lecturer in Respiratory Sciences by the Institute of Circulatory and Respiratory Health (ICRH) of the Canadian Institutes of Health Research (CIHR) and by the Canadian Thoracic Society (CTS). This award recognizes an individual's outstanding contribution to the advancement of respiratory sciences, both in Canada and internationally, at the midpoint of their career. As the recipient, Prof. Divangahi will deliver a keynote lecture at the Canadian Respiratory Conference in April 2024.
“This is a great honour and well deserved for the outstanding work he has published over the past several years in the area of host-pathogen interactions in the lung, including a recent paper in Nature,” says Dr. Basil Petrof, co-leader of the Translational Research in Respiratory Diseases (RESP) Program at the Research Institute of the McGill University Health Centre (RI-MUHC) and director of the Meakins-Christie Laboratories. “We are extremely proud that this year, both of the CIHR-CTS distinguished lectureships have been awarded to members of our group – the other recipient being Dr. Jean Bourbeau.”
An internationally recognized pulmonary immunologist, Maziar Divangahi is a professor of medicine at McGill University, associate director of the Meakins-Christie Laboratories and associate director of the McGill International TB Centre. He is also a senior scientist at the RI-MUHC, where he conducts research in the RESP Program and at the Centre for Translational Biology. The overarching focus of his research program is to investigate the regulatory mechanisms involved in host resistance and disease tolerance against major pulmonary bacterial (Mycobacterium tuberculosis) and viral (influenza virus and SARS-CoV2) pathogens. He is currently investigating how to harness the power of innate memory response (trained immunity) in vaccine development.
Throughout his career, he has been a prolific investigator publishing in outstanding journals and has received numerous awards, including a CIHR New Investigator Award, FRQS Award, and the CIHR Foundation grant. His scholarly work has been recognized by election to the Royal Society of Canada. He currently holds the Strauss Chair in Respiratory Diseases.
Congratulations, Prof. Divangahi!
Related news
Alveolar macrophages on patrol for respiratory health
Dr. Jean Bourbeau honoured by the Canadian Institutes for Health Research and Canadian Thoracic Society